Back

Prevalence, Genotyping, and Mutational Analysis of Hepatitis B Virus in HIV-Infected Patients on Antiretroviral Therapy in Nairobi, Kenya

Ochieng, L. A.; Macharia, R. W.; Mwau, M.

2026-05-08 hiv aids
10.64898/2026.05.06.26352536 medRxiv
Show abstract

BackgroundHepatitis B virus infection remains a major public health challenge, particularly among people living with human immunodeficiency virus, due to shared transmission routes and the potential for accelerated liver disease progression. Molecular characterization of circulating HBV strains is essential for understanding viral epidemiology, mutation patterns, and implications for diagnostics and vaccination. MethodsThis study investigated the prevalence of hepatitis B infection and molecular characteristics of the hepatitis B virus surface gene among HIV-infected individuals receiving antiretroviral therapy in Nairobi County, Kenya. Plasma samples were screened for hepatitis B surface antigen using enzyme-linked immunosorbent assay. Hepatitis B viral DNA was extracted from HBsAg-positive samples and the surface gene region amplified by polymerase chain reaction. Amplified products were subjected to Sanger sequencing. Sequence assembly, genotype determination, and mutation analysis. ResultsThe prevalence of HIV/HBV co-infection among HIV-positive individuals was determined to be 8.97%. Genotype analysis revealed the circulation of HBV genotype A (sub-genotypes A1 and A4) and genotype D (sub-genotypes D4 and D10) among the studied population. Amino acid sequence analysis of the major hydrophilic region of the surface gene identified several mutations, with R122K and Y134F being the most frequently observed substitutions. ConclusionHepatitis B infection remains prevalent among HIV-infected individuals receiving antiretroviral therapy in Nairobi County. The circulation of multiple hepatitis B virus genotypes and the presence of mutations within the surface gene highlight the importance of continuous molecular surveillance to monitor viral evolution and its potential implications for hepatitis B virus diagnosis, vaccination strategies, and clinical management in HIV-infected populations

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
PLOS ONE
5266 papers in training set
Top 4%
31.2%
2
Journal of General Virology
53 papers in training set
Top 0.1%
11.1%
3
Journal of Medical Virology
140 papers in training set
Top 0.4%
4.9%
4
Open Forum Infectious Diseases
142 papers in training set
Top 0.5%
4.9%
50% of probability mass above
5
Health Science Reports
13 papers in training set
Top 0.1%
4.1%
6
Journal of Antimicrobial Chemotherapy
46 papers in training set
Top 0.3%
3.2%
7
Journal of Clinical Virology
63 papers in training set
Top 0.2%
3.2%
8
Infection, Genetics and Evolution
42 papers in training set
Top 0.3%
2.5%
9
Viruses
332 papers in training set
Top 2%
2.1%
10
Frontiers in Microbiology
427 papers in training set
Top 5%
1.9%
11
Journal of Virology
499 papers in training set
Top 2%
1.7%
12
Scientific Reports
3612 papers in training set
Top 56%
1.7%
13
PLOS Global Public Health
344 papers in training set
Top 6%
1.5%
14
Infectious Diseases of Poverty
11 papers in training set
Top 0.2%
1.3%
15
BMC Infectious Diseases
133 papers in training set
Top 3%
1.3%
16
The Journal of Infectious Diseases
202 papers in training set
Top 3%
1.1%
17
Clinical Infectious Diseases
235 papers in training set
Top 2%
1.1%
18
Frontiers in Public Health
148 papers in training set
Top 5%
1.1%
19
BMJ Open
601 papers in training set
Top 12%
1.0%
20
Epidemiology and Infection
89 papers in training set
Top 2%
0.9%
21
PLOS Neglected Tropical Diseases
466 papers in training set
Top 5%
0.9%
22
Heliyon
152 papers in training set
Top 8%
0.8%
23
Cureus
68 papers in training set
Top 4%
0.8%
24
Pan African Medical Journal
11 papers in training set
Top 0.7%
0.6%
25
Sexually Transmitted Infections
23 papers in training set
Top 0.5%
0.6%